Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Glioblastoma 30Carcinoma, Non-Small-Cell Lung 30Lung Neoplasms 23Head and Neck Neoplasms 21Squamous Cell Carcinoma of Head and Neck 15Lymphoma 15Gliosarcoma 15Central Nervous System Neoplasms 14Sarcoma 12Esophageal Neoplasms 12Rectal Neoplasms 10Glioma 10Leukemia 9Breast Neoplasms 9Brain Neoplasms 9Prostatic Neoplasms 8Pancreatic Neoplasms 8Lymphoma, Follicular 7Esophageal Squamous Cell Carcinoma 7Neoplasms 6Melanoma 6Leukemia, Lymphocytic, Chronic, B-Cell 6Uterine Cervical Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Astrocytoma 5

Interventions

Cisplatin 3Cetuximab 3pembrolizumab 2zalutumumab 1temsirolimus 1osimertinib 1cobimetinib 1Taxes 1Sorafenib 1Radiotherapy 1Pemetrexed 1Paclitaxel 1Nivolumab 1Injections 1Fluorouracil 1Cilengitide 1Carboplatin 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasms, Squamous Cell × Radiotherapy × Clear all
NCT00401401 2011-12-23

Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer

Genmab

Phase 1/2 Terminated
30 enrolled 13 charts
Head & Neck

Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡